We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Sequencing System Increases Data Production While Reducing Costs.

By LabMedica International staff writers
Posted on 27 Jan 2010
Researchers engaged in human genome sequencing and profiling will benefit from the introduction of a new, low cost, high output system.

The new instrument, the Illumina Inc. More...
(San Diego, CA, USA) HiSeq 2000, is capable of generating two billion paired-end reads and 200 gigabases (Gb) of quality filtered data in a single run. The system uses two flow cells and an innovative dual-surface imaging method, enabling new levels of sequencing output as well as experimental flexibility.

For the operator the HiSeq 2000 offers streamlined and intuitive single operator workflow; initiating a run requires less than 10 minutes total hands-on time. Preconfigured plug-and-play reagents, a touch screen user interface, and real-time and remote run monitoring result in simpler instrument operation. Jay Flatley, president and CEO of Illumina, said, "These innovations redefine the trajectory of sequencing and, for the first time, take the cost of sequencing a human genome below $10,000."

"HiSeq will have a major impact on a broad range of applications, including advancing our understanding of cancer and other complex genetic diseases. We can now sequence two human genomes in a single run--for example, a tumor and a normal sample--at 30-fold coverage," said Dr. David Bentley, vice president and chief scientist at Illumina. "The unprecedented output and cost-effective operation will make human genome sequencing routine and allow researchers to easily compare entire genomes, transcriptomes, and epigenomes."

The HiSeq 2000 sequencing system began shipping in limited quantities to selected sites in February 2009, and is expected to ship broadly in March 2010.

Related Links:

Illumina Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Clinical Informatics Platform
CLARION™
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.